Epigenetic regulation by CpG methylation has an important role in tumorigenesis as well as in the response to cancer therapy. To analyze the mechanism of epigenetic control of radiosensitivity, the CpG methylation profiles of radiosensitive H460 and radioresistant H1299 human non-small cell lung cancer (NSCLC) cell lines were analyzed using microarray profiling. These analyses revealed 1091 differentially methylated genes (DMG) (absolute difference of mean b-values, |Db % |40.5), including genes involved in cell adhesion, cell communication, signal transduction and transcriptional regulation. Among the 747 genes hypermethylated in radioresistant H1299 cells, CpG methylation of SERPINB5 and S100A6 in radioresistant H1299 cells was confirmed by methylationspecific PCR. Reverse transcriptase-PCR showed higher expression of these two genes in radiosensitive H460 cells compared with radioresistant H1299 cells. Downregulation of SERPINB5 or S100A6 by small interfering RNA in H460 cells increased the resistance of these cells to ionizing radiation. In contrast, promoter CpG sites of 344 genes, including CAT and BNC1, were hypomethylated in radioresistant H1299 cells. Suppression of CAT or BNC1 mRNA expression in H1299 cells also reduced the resistance of these cells to ionizing radiation. Thus, we identified DMGs by genome-wide CpG methylation profiling in two NSCLC cell lines with different responses to ionizing radiation, and our data indicated that these differences may be critical for epigenetic regulation of radiosensitivity in lung cancer cells.
Introduction
During mammalian development, CpG islands in DNA are methylated de novo in a tissue-specific manner, and the patterns are fixed in subsequent cell divisions by methyltransferase activity (Kafri et al., 1992) . Although housekeeping genes remain available for transcription, tissue-specific genes are maintained in a closed chromatin conformation by DNA methylation. Promoter region hypermethylation of CpG islands and associated histone modifications have a role in the aberrant silencing of genes required to maintain normal cellular proliferation and differentiation.
Epigenetic regulation of tumor-suppressor genes by promoter CpG hypermethylation and histone deacetylation is an important step in tumorigenesis (McCabe et al., 2009) . DNA hypermethylation in human cancers is especially important for the application of demethylating agents as cancer therapeutics (Ehrlich, 2002) ; however, hypermethylation confers only short-term anticancer effects and may even promote tumor progression of surviving cancer cells. DNA hypomethylation in repeat sequences is also associated with human cancers. In addition, this site-specific hypomethylation of certain genes including oncogenes may, in fact, contribute to the development of cancer as well as other diseases (Jones and Baylin, 2007) . In this sense, genomewide CpG methylation analysis in tumorigenesis models is important to understand the role of DNA methylation in tumorigenesis. In fact, DNA methylation profiling has been suggested as a critical analysis for cancer classification (Esteller et al., 2002; Jones and Baylin, 2007) . Recent genome-wide promoter methylation profiling analyses have enabled the identification of potential methylation markers in melanoma and prostate cancer (Koga et al., 2009; Kron et al., 2009) .
Dysregulated epigenetic control through DNA methylation and histone modifications is important for radioresistance of cancer cells. Aberrant methylation of multiple CpG dinucleotides within the proximal promoter region of the ataxia telangiectasia mutated gene leads to radioresistance in a human colorectal tumor cell line . The ataxia telangiectasia mutated promoter also seemed to be hypermethylated in a radiosensitive glioma cell line, and demethylation by 5-aza-2 0 -deoxycytidine treatment increased radioresistance (Roy et al., 2006) . Epigenetically downregulated RUNX3 was associated with radioresistance in esophageal cancer (Sakakura et al., 2007) , and hypermethylation of tumor-suppressor genes in the Ras/phosphatidylinositol 3 kinase/AKT pathway was related to poor response to radiotherapy in oral squamous cell carcinoma .
To elucidate the mechanism of radioresistance of cancer cells at the whole-genome or proteome level, several studies have reported profiled gene expression (Park et al., 2002; Amundson et al., 2005) or proteome information (An and Seong, 2006; Skvortsova et al., 2008) related to radioresistance. However, no previous study has reported on the global analysis of aberrant CpG methylation related to radioresistance in cancer cells. Therefore, we analyzed genome-wide CpG methylation profiles from two human non-small cell lung cancer (NSCLC) cell lines with different radiosensitivities. Among the 14 495 genes analyzed with the methylation-specific microarray, 1091 genes were identified as differentially methylated genes (DMGs). To validate the epigenetic control of DMGs for radioresistance, we selected two hypermethylated and two hypomethylated genes that had the most significant differences in CpG methylation between the two cell lines: serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5); S100 calcium-binding protein A6 (S100A6); catalase (CAT); and basonuclin 1 (BNC1). The physiological role of these genes in the sensitivity to ionizing radiation was also examined by knockdown using small interfering RNA (siRNA). From the results of these experiments, we identified the epigenetically regulated genes related to radiosensitivity in human lung cancer cell lines.
Results

Differential CpG methylation between two NSCLC cell lines
The human NSCLC H1299 cell line is more resistant to ionizing radiation than the H460 cell line (Jeong et al., 2009) . To analyze the potential significance of CpG methylation on the different responses to ionizing radiation, we examined the genome-wide differential methylation profiles in these two lung cancer cell lines and two normal human lung cell types, small airway epithelial cells (SAECs) and WI38 normal human fetal lung fibroblasts. The methylation level at a CpG site is described as a continuous variable b-value, and a value of 0 indicates a fully unmethylated site while a value of 1 indicates a fully methylated site. A similar bimodal b-value distribution was observed for the two lung cancer cell lines ( Figures 1a and b) ; however, H1299 cells showed slightly greater proportion of hypermethylated CpG sites than H460 cells. Approximately 18.7% of the CpG sites (b-value 40.8) were considered hypermethylated in H1299 cells, whereas 15.9% of the CpG sites were hypermethylated in H460 cells. In contrast, the methylation profile clearly showed that normal cells are highly undermethylated relative to cancer cells and that hypermethylated sites comprise only a small proportion of the total CpG sites (8-9%), which is less than half of the hypermethylated proportion in cancer cells ( Figures  1c and d) . In the two lung cancer cells, 1348 CpG sites in 1091 genes were denoted as DMGs that passed two significance criteria (see Materials and methods; Figure 1e ). Among the final 1091 DMGs, the CpG sites of 747 genes were hypermethylated (the difference of mean b-values Db % 40.5) in radioresistant H1299 cells, whereas 344 genes were hypomethylated (Db % oÀ0.5) in these cells. The complete gene lists are presented in Supplementary Table S1 .
The results of the gene set analyses and DMGs are shown in Table 1 . The most significant annotation clusters of enriched gene sets (Po0.05) were inferred from functional annotation analysis with DMGs according to the methylation status. Hypermethylated genes in the H1299 cells were enriched for genes involved in cell communication, signal transduction and cell adhesion, whereas hypomethylated genes in the H1299 cells were significantly and exclusively related to transcriptional regulation (Table 1) .
Validation of CpG methylation and mRNA expression
To validate the epigenetic control of DMGs for radioresistance, we selected two hypermethylated and two hypomethylated genes from the genes with the most significant differences in CpG methylation between the two cell lines (|Db % | 40.75). These genes were SERPINB5 (Db % ¼ 0.86); S100A6 (Db % ¼ 0.93); CAT (Db % ¼ À0.90); and BNC1 (Db % ¼ À0.75), respectively (Supplementary Table  S1 ). The expressions of SERPINB5, S100A6, CAT and BNC1 were examined by reverse transcriptase (RT)-PCR ( Figure 2a ). The levels of SERPINB5 and S100A6 gene expression were higher in the H460 cells, whereas CAT and BNC1 were more highly expressed in the H1299 cells. We also confirmed the methylation status of each gene by methylation-specific PCR analysis ( Figure 2b ). After treatment of H1299 cells with the demethylating agent 5-aza-2 0 -deoxycytidine, expression of SERPINB5 and S100A6 was increased as detected by RT-PCR (Figure 2c ), and CpG methylation of the promoter was also reverted (Figure 2d ). In addition, CAT and BNC1 expression were also restored in H460 cells after 5-aza-2 0 -deoxycytidine treatment ( Figure 2c ). As a positive control, we tested the expression and methylation of RASSF1A (Figure 2c ).
Effect of epigenetically controlled genes on radiosensitivity Gene expression of SERPINB5 and S100A6 is reportedly controlled by methylation (Futscher et al., 2002; Rehman et al., 2004) ; however, the effect of SERPINB5 and S100A6 expression on radiosensitivity has not been studied in depth, although expression of these genes is induced by ionizing radiation (Nagtegaal et al., 2005; Orre et al., 2007) . Using siRNAs, we lowered the levels of SERPINB5 and S100A6 in H460 cells and then examined the cell survival rate after exposure to g-irradiation at 2, 5 or 8 Gy (Figure 3 ). The suppression of SERPINB5 and S100A6 increased radioresistance in H460 cells.
The expression of CAT and BNC1 has also been reported to be regulated epigenetically (Ding et al., 2004; Shames et al., 2006; Dunwell et al., 2009) . Recent study revealed that overexpression of CAT increased radioresistance (Epperly et al., 2009 ). In addition, BNC1 is known to be involved in cell proliferation of keratinocytes (Tseng and Green, 1994) , but the function of this gene has not yet been clearly defined. Knockdown of CAT and BNC1 expression in H1299 cells by siRNA lowered the sensitivity of these cells to ionizing radiation in a clonogenic assay (Figure 4 ).
Discussion
The abnormal gene expression in tumor cells may result from alterations in copy number, sequence mutations and/or epigenetic effects. Malignant cancer cells show major disruptions in DNA methylation profiles, and these changes include aberrant hypermethylation or hypomethylation of gene promoters as well as global genomic hypomethylation (McCabe et al., 2009) . In this study, we performed whole-genome analysis of CpG methylation in two NSCLC cell lines and two normal human lung cell types to examine the genome-wide epigenetic control of radioresistance.
We identified 1091 DMGs in two NSCLC cell lines, providing a list of potential genes that may be controlled epigenetically to affect radioresponsiveness (Supplementary Table S1 ). Although both cell lines showed a similar bimodal distribution of methylation b-values (Figure 1 ), the number of hypermethylated genes in radioresistant H1299 cells was double the number of hypermethylated genes in radiosensitive H460 cells. Regarding the general progress of cancer cells toward more radioresistance, we suggest that H1299 is more progressed cancerous cell line than H460 in concordance with a higher proportion of hypermethylated CpG sites in H1299 cells. The hypermethylation of SERPINB5 and S100A6 enhanced the radioresistance of these cells, whereas the CpG methylation of CAT and BNC1 was important to increase the radiosensitivity. From these results, we Global analysis of CpG methylation for radiosensitivity E-H Kim et al suggest that the examination of DNA methylation of each gene involved in radiosensitivity is necessary as this information is important for the use of demethylating agents as radiotherapy sensitizers or chemotherapeutics. The use of demethylating agents would be beneficial for the treatment of cancer cells that contain hypermethylated SERPINB5 and S100A6; however, these same agents may actually lead to radioresistance in cancer cells with hypermethylated CAT and BNC1. Nevertheless, considering that all four genes are hypomethylated in normal SAECs (Supplementary Table S1 ), demethylating chromosomal DNA of cancer cells may restore globally balanced conditions similar to those observed in normal cells. SERPINB5, a mammary serine protease inhibitor, has been reported to inhibit tumor cell invasion and metastasis in breast cancer (Maass et al., 2000) . DNA damage induced by cytotoxic chemicals induces the Effect of SERPINB5 and S100A6 on radiosensitivity of H460 cells. mRNA expression after transfection of siRNA constructs (a, c) and the survival curve of H460 cells after irradiation (b, d). Total RNA was prepared from H460 cells transfected with siSERPINB5, siS100A6 or siNC (negative control) for 24 h. Levels of SERPINB5 and S100A6 mRNA were normalized to that of GAPDH. After siRNA transfection, cells were plated and irradiated with different doses of g-irradiation (2, 5, or 8 Gy). À and þ indicate siNC and siSERPINB5 (or S100A6), respectively. All experiments were performed in triplicate. *Po0.1, as compared with negative control.
Global analysis of CpG methylation for radiosensitivity
E-H Kim et al expression of SERPINB5 through p53 (Zou et al., 2000) . In addition, the SERPINB5 promoter is regulated by methylation and histone acetylation in a tissue-specific manner (Futscher et al., 2002) . The promoter CpG of the SERPINB5 gene was hypermethylated in radioresistant H1299 cells. When we suppressed SERPINB5 expression in radiosensitive H460 cells, cell survival increased in response to 8 Gy g-irradiation (P ¼ 0.07). Furthermore, SERPINB5 mRNA expression and CpG methylation patterns correlated well with their responses to ionizing radiation. The S100A6 promoter region was enriched with CpG sites, which were controlled by DNA methylation (Rehman et al., 2004) . In this study, the knockdown of the S100A6 gene by siRNA increased the radioresistance of H460 cells at dose of 5 Gy girradiation (P ¼ 0.09). Overall, the cell survival fractions increased with knockdown of SERPINB5 and S100A6 mRNA levels. Antioxidants such as CAT, superoxide dismutase, glutathione peroxidase and glutathione reductase were activated on exposure to ionizing radiation. Upregulation of antioxidant proteins led to radioresistance (Epperly et al., 2009 ) and resistance to the antitumor agent cisplatin (Wang et al., 2008) . Hypomethylation of the CAT gene at exon 2 was detected in colon tumor specimens (Ribieras et al., 1994) . In this study, we have shown that the CAT promoter CpGs in H1299 cells were hypomethylated and that knockdown of CAT in H1299 cells resulted in increased sensitivity to ionizing radiation. BNC1 is a cell type-specific transcription factor expressed mainly in the proliferative keratinocytes of stratified epithelium and the gametogenic cells in testes and ovaries. BNC1 regulates transcription of genes related to ribosomes, chromatin structure, transcription regulation, cell-cell junction/communication, ion channels and intracellular transportation. Null mutations in BNC1 disrupt corneal epithelium homeostasis and delay wound healing by impairing cell proliferation (Zhang and Tseng, 2007) . In addition, BNC1 promoter methylation has been reported previously (Shames et al., 2006; Dunwell et al., 2009) . In this study, we showed that epigenetic regulation of BNC1 in NSCLC cells conferred radioresistance.
We have analyzed the CpG methylation profiles in two NSCLC cell lines to examine epigenetically regulated radioresistance. We found that several key regulators in radiosensitivity were epigenetically controlled by CpG methylation. Therefore, demethylating agents used as chemotherapeutics should be carefully applied to treat cancers according to the methylation profiles of each cancer patient. Further integrated analysis of CpG methylation and mRNA expression profiles is necessary to provide more precise information regarding the epigenetic regulation of radiosensitivity in lung cancer cell lines.
Materials and methods
Cell culture and treatment with ionizing radiation H460 and H1299 cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine. The cells were exposed to 0, 2, 5 or 8 Gy g-irradiation using a 4MV linear accelerator (Clinac 4/100, Varian, Palo Alto, CA, USA) as described previously (Park et al., 2002) . Normal human SAECs and specific medium were purchased from PromoCell (Heidelberg, Germany). SAECs were maintained in serum-free SAGM supplemented with bovine pituitary extract, 10 ng/ml epidermal growth factor, 5 mg/ml insulin, 0.5 mg/ml hydrocortisone, 0.5 mg/ml epinephrine, 10 mg/ml transferrin and 0.1 ng/ml retinoic acid. The tenth passage of SAECs was used for genomic DNA extraction for microarray analysis. WI38 human diploid fibroblast cell lines (ATCC, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 mg/ml streptomycin.
Profiling of CpG methylation using microarrays
Genomic DNA was extracted from H1299, H460, WI38 cells and normal human SEACs using Qiagen Blood and Cell Figure 4 Effect of CAT and BNC1 on radiosensitivity in H1299 cells. mRNA expression after siRNA transfection (a, c) and the survival curve of H1299 cells after irradiation (b,d) . Total RNA was prepared from H1299 cells transfected with siCAT, siBNC1 or siNC (negative control) for 24 h. Levels of CAT and BNC1 mRNA were normalized to that of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). After siRNA transfection, cells were plated and irradiated with different doses of g-irradiation (2, 5 or 8 Gy). À and þ indicate siNC and siCAT (or BNC1), respectively. All experiments were performed in triplicate. **Po0.05; ***Po0.01 as compared with negative control.
Culture DNA Kits (Qiagen, Valencia, CA, USA) according to the manufacturer's protocols. For the analysis of CpG methylation, the Illumina HumanMethylation27 BeadChip containing 27 578 individual CpG sites from 14 495 genes was used (Illumine, San Diego, CA, USA). The methylation values for individual CpG sites in each sample were obtained as bvalues. The b-value is a continuous variable that is calculated by dividing the intensity of the methylated beads by the combined intensity, and these values range from 0 (completely unmethylated) to 1 (completely methylated). To identify DMGs in the H1299 and H460 cell lines, we applied two significance criteria, the Student's t-test P-value and the difference in mean b-values (Db % ). The genes were defined as DMGs if their t-test P-values were significant at a false discovery rate threshold of 0.05 (Benjamini and Hochberg, 1995) and the absolute differences of mean b-values (|Db % |) between the two cell lines were 40.5. The t-test P-values and Db % s were obtained from triplicate array data. With the above significance criteria, only nine genes showed incongruent differential methylation levels in multiple CpG sites, containing both significantly hyper-or hypo-methylated sites, and thus, these genes were excluded from further analysis. The resulting differential methylation profiles were analyzed with DAVID bioinformatics resources for gene set analysis (Huang da et al., 2009) , and approximately 14 300 genes in the HumanMethylation27 BeadChip were used as background.
RNA preparation and quantitative real-time-PCR
Total RNA was extracted from cell lines using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. One microgram of total RNA was converted to complementary DNA using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and oligo-(dT) 12-18 primers (Invitrogen) according to the manufacturer's protocol. The quantitative RT-PCR was performed in a total reaction mixture containing complementary DNA, SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan), Rox reference dye and primers for each gene. Samples were analyzed with the ABI PRISM 7000 sequence detection system (Applied BioSystems, Foster City, CA, USA). All PCRs were performed in triplicate, and the specificity of the reaction was determined by melting curve analysis at the dissociation stage. We synthesized specific primers for SERPINB5 (forward 5
siRNA transfection and clonogenic assay The siRNAs against SERPINB5, S100A6, CAT and BNC1 (ON-TARGETplus SMARTpool) were transfected into cells using DharmaFECT 2 reagents according to the manufacturer's recommendations (Dharmacon, Lafayette, CO, USA). Gene expression in each sample was confirmed by quantitative RT-PCR 24 h after transfection. The siRNA-transfected cells (200-1000 per well) were plated for exposure to various doses of irradiation. After irradiation, the cells were cultured for approximately 2 weeks, depending on the cell line. The colonies were fixed with methanol and stained with crystal violet. Colonies containing more than 50 cells were scored as survivors, and the data were normalized to the control group. All experiments were repeated at least three times. All data are presented as mean ± s.d. The Student's t-test was used to compare the means of the different groups. A P-value o0.05 was considered statistically significant.
Methylation-specific PCR and 5-aza-2 0 -deoxycytidine treatment Bisulfite modification of genomic DNA was carried out using the EpiTect Bisulfite Kit (Qiagen). Methylation-specific PCR was performed with bisulfite-treated DNA as the template using specific primer sequences for the methylated or unmethylated forms of the gene. H460 and H1299 lung cancer cells were plated at 5 Â 10 5 per 100-mm culture dish on the day before the treatment. Cells were treated with 5-aza-2 0 -deoxycytidine (Sigma-Aldrich, St Louis, MO, USA) or dimethylsulphoxide vehicle at a final concentration of 10 mM for 4 days, and the medium was renewed daily. Treated cells were harvested at the end of the fifth day. Genomic DNA and total RNA were isolated using QIAamp DNA Blood Mini Kit and RNeasy Mini Kit (Qiagen), respectively. The following methylation-specific primers were used: SERPINB5 (M forward, 5 
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